| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |